MBMatteo Bulloni

Matteo Bulloni

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Matteo Bulloni has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prediction of in-hospital atrial fibrillation after acute myocardial infarction: a cross-cohort study in Italian and Finnish patients

    by Matteo Bulloni, Miriana Torquati, Roni Ahola, Alice Bonesi, Marion Taconné, Antti Vehkaoja, Felix Tirschmann, Antti Kallonen, Pedro Moreno-Sánchez, Leo-Pekka Lyytikäinen, et al.

  • Open Access

    Automated Analysis of Proliferating Cells Spatial Organisation Predicts Prognosis in Lung Neuroendocrine Neoplasms

    by Matteo Bulloni, Giada Sandrini, Irene Stacchiotti, Massimo Barberis, Fiorella Calabrese, Lina Carvalho, Gabriella Fontanini, Greta Alì, Francesco Fortarezza, Paul Hofman, et al.

    Lung neuroendocrine neoplasms (lung NENs) are categorised by morphology, defining a classification sometimes unable to reflect ultimate clinical outcome. Subjectivity and poor reproducibility characterise diagnosis and prognosis assessment of all NENs. Here, we propose a machine learning framework for tumour prognosis assessment based on a quantitative, automated and repeatable evaluation of the spatial distribution of cells immunohistochemically positive for the proliferation marker Ki-67, performed on the entire extent of high-resolution whole slide images. Combining features from the fields of graph theory, fractality analysis, stochastic geometry and information theory, we describe the topology of replicating cells and predict prognosis in a histology-independent way. We demonstrate how our approach outperforms the well-recognised prognostic role of Ki-67 Labelling Index on a multi-centre dataset comprising the most controversial lung NENs. Moreover, we show that our system identifies arrangement patterns in the cells positive for Ki-67 that appear independently of tumour subtyping. Strikingly, the subset of these features whose presence is also independent of the value of the Labelling Index and the density of Ki-67-positive cells prove to be especially relevant in discerning prognostic classes. These findings disclose a possible path for the future of grading and classification of NENs.